Lowe Wealth Advisors’s GSK GSK Stock Holding History

Lowe Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48	Closed	-$2K	–	301
2019 Q1	$2K	Hold	48	–	–	﹤0.01%	224
2018 Q4	$2K	Hold	48	–	–	﹤0.01%	212
2018 Q3	$2K	Hold	48	–	–	﹤0.01%	256
2018 Q2	$2K	Hold	48	–	–	﹤0.01%	200
2018 Q1	$2K	Hold	48	–	–	﹤0.01%	206
2017 Q4	$2K	Hold	48	–	–	﹤0.01%	217
2017 Q3	$2K	Hold	48	–	–	﹤0.01%	209
2017 Q2	$3K	Hold	48	–	–	﹤0.01%	176
2017 Q1	$3K	Hold	48	–	–	﹤0.01%	175
2016 Q4	$2K	Hold	48	–	–	﹤0.01%	192
2016 Q3	$3K	Hold	48	–	–	﹤0.01%	186
2016 Q2	$3K	Buy	+48	New	+$2.53K	﹤0.01%	180
2015 Q3	–	Sell	-800	Closed	-$42K	–	235
2015 Q2	$42K	Hold	800	–	–	0.03%	75
2015 Q1	$46K	Hold	800	–	–	0.03%	73
2014 Q4	$43K	Buy	+800	New	+$44.8K	0.03%	73

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lowe Wealth Advisors's GSK Position: Q2 2019 in Review

Lowe Wealth Advisors sold out of GSK (GSK) in Q2 2019, closing a stake of 48 shares — an estimated $2K sold.

Lowe Wealth Advisors first reported a position in GSK in Q4 2014 and held it in 15 quarters. The position peaked at $46K in Q1 2015. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Lowe Wealth Advisors reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Lowe Wealth Advisors sold 48 GSK shares in Q2 2019, an estimated $2K.
Lowe Wealth Advisors first reported a position in GSK in Q4 2014 and held it in 15 quarters.
Lowe Wealth Advisors's GSK position peaked at $46K in Q1 2015.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Lowe Wealth Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.